Clinical Trial Update: A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of a continuous intravenous infusion of Endostar combined with pemetrexed and carboplatin in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Endostar (recombinant human endostatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED